Thomas Gad - Net Worth and Insider Trading
Thomas Gad Net Worth
The estimated net worth of Thomas Gad is at least $3 Million dollars as of 2024-11-29. Thomas Gad is the CHIEF BUSINESS OFFICER of Y-mAbs Therapeutics Inc and owns about 286,381 shares of Y-mAbs Therapeutics Inc (YMAB) stock worth over $3 Million. Details can be seen in Thomas Gad's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas Gad has not made any transactions after 2024-09-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas Gad
Thomas Gad Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas Gad owns 1 companies in total, including Y-mAbs Therapeutics Inc (YMAB) .
Click here to see the complete history of Thomas Gad’s form 4 insider trades.
Insider Ownership Summary of Thomas Gad
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| YMAB | Y-mAbs Therapeutics Inc | 2024-09-16 | director & President and Chairman |
Thomas Gad Latest Holdings Summary
Thomas Gad currently owns a total of 1 stock. Thomas Gad owns 286,381 shares of Y-mAbs Therapeutics Inc (YMAB) as of September 16, 2024, with a value of $3 Million.
Latest Holdings of Thomas Gad
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| YMAB | Y-mAbs Therapeutics Inc | 2024-09-16 | 286,381 | 11.88 | 3,402,206 |
Holding Weightings of Thomas Gad
Thomas Gad Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas Gad has made a total of 65 transactions in Y-mAbs Therapeutics Inc (YMAB) over the past 5 years, including 0 buys and 65 sells. The most-recent trade in Y-mAbs Therapeutics Inc is the sale of 95,000 shares on September 16, 2024, which brought Thomas Gad around $1 Million.
Insider Trading History of Thomas Gad
- 1
Thomas Gad Trading Performance
Thomas Gad Ownership Network
Thomas Gad Owned Company Details
What does Y-mAbs Therapeutics Inc do?
Who are the key executives at Y-mAbs Therapeutics Inc?
Thomas Gad is the director & President and Chairman of Y-mAbs Therapeutics Inc. Other key executives at Y-mAbs Therapeutics Inc include Sr. VP and Head of Tech Op Torben Lund-hansen , Sr. VP and COO Joris Wilms , and director & EVP & CFO & Secy & Treas. Bo Kruse .
Y-mAbs Therapeutics Inc (YMAB) Insider Trades Summary
Over the past 18 months, Thomas Gad made 6 insider transaction in Y-mAbs Therapeutics Inc (YMAB) with a net sale of 501,251. Other recent insider transactions involving Y-mAbs Therapeutics Inc (YMAB) include a net purchase of 279,028 shares made by Biotech Aps Wg , a net purchase of 279,028 shares made by Johan Wedell-wedellsborg , and a net sale of 60,000 shares made by Bo Kruse .
In summary, during the past 3 months, insiders sold 95,000 shares of Y-mAbs Therapeutics Inc (YMAB) in total and bought 0 shares, with a net sale of 95,000 shares. During the past 18 months, 620,366 shares of Y-mAbs Therapeutics Inc (YMAB) were sold and 558,056 shares were bought by its insiders, resulting in a net sale of 62,310 shares.
Y-mAbs Therapeutics Inc (YMAB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Y-mAbs Therapeutics Inc Insider Transactions
Thomas Gad Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas Gad. You might contact Thomas Gad via mailing address: C/o Y-mabs Therapeutics, Inc., 230 Park Avenue, 33rd Floor, New York Ny 10169.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
